László, K.; Vörös, D.; Correia, P.; Fazekas, C.L.; Török, B.; Plangár, I.; Zelena, D.
Vasopressin as Possible Treatment Option in Autism Spectrum Disorder. Biomedicines 2023, 11, 2603.
https://doi.org/10.3390/biomedicines11102603
AMA Style
László K, Vörös D, Correia P, Fazekas CL, Török B, Plangár I, Zelena D.
Vasopressin as Possible Treatment Option in Autism Spectrum Disorder. Biomedicines. 2023; 11(10):2603.
https://doi.org/10.3390/biomedicines11102603
Chicago/Turabian Style
László, Kristóf, Dávid Vörös, Pedro Correia, Csilla Lea Fazekas, Bibiána Török, Imola Plangár, and Dóra Zelena.
2023. "Vasopressin as Possible Treatment Option in Autism Spectrum Disorder" Biomedicines 11, no. 10: 2603.
https://doi.org/10.3390/biomedicines11102603
APA Style
László, K., Vörös, D., Correia, P., Fazekas, C. L., Török, B., Plangár, I., & Zelena, D.
(2023). Vasopressin as Possible Treatment Option in Autism Spectrum Disorder. Biomedicines, 11(10), 2603.
https://doi.org/10.3390/biomedicines11102603